Engineers Gate Manager LP Nektar Therapeutics Transaction History

Engineers Gate Manager LP

  • $4.86 Billion
  • Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Engineers Gate Manager LP holds 13,398 shares of NKTR stock, worth $12,192. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,398
Holding current value
$12,192
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.11 - $1.48 $14,871 - $19,829
13,398 New
13,398 $17,000
Q4 2022

Feb 14, 2023
BUY
$2.03 - $4.28 $41,826 - $88,185
20,604 New
20,604 $46,000
Q2 2022

Aug 15, 2022
SELL
$3.17 - $6.17 $178,810 - $348,031
-56,407 Reduced 39.35%
86,957 $330,000
Q1 2022

May 16, 2022
BUY
$4.16 - $13.72 $532,621 - $1.76 Million
128,034 Added 835.19%
143,364 $773,000
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $166,023 - $282,225
15,330 New
15,330 $207,000
Q3 2021

Nov 15, 2021
SELL
$13.07 - $18.84 $1.69 Million - $2.43 Million
-129,105 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$16.52 - $20.4 $1.65 Million - $2.04 Million
100,174 Added 346.25%
129,105 $2.22 Million
Q1 2021

May 17, 2021
SELL
$16.56 - $25.46 $1.86 Million - $2.86 Million
-112,464 Reduced 79.54%
28,931 $579,000
Q4 2020

Feb 16, 2021
BUY
$15.77 - $19.03 $1.69 Million - $2.04 Million
107,002 Added 311.12%
141,395 $2.4 Million
Q3 2020

Nov 16, 2020
BUY
$16.59 - $24.79 $332,695 - $497,138
20,054 Added 139.86%
34,393 $571,000
Q2 2020

Aug 17, 2020
SELL
$16.86 - $23.44 $416,273 - $578,733
-24,690 Reduced 63.26%
14,339 $332,000
Q1 2020

May 15, 2020
BUY
$14.47 - $27.96 $315,865 - $610,338
21,829 Added 126.91%
39,029 $697,000
Q4 2019

Feb 14, 2020
SELL
$15.87 - $23.12 $1.92 Million - $2.8 Million
-120,942 Reduced 87.55%
17,200 $371,000
Q3 2019

Nov 14, 2019
BUY
$16.91 - $36.27 $2.11 Million - $4.52 Million
124,664 Added 924.94%
138,142 $2.52 Million
Q2 2019

Aug 14, 2019
SELL
$31.0 - $36.3 $107,322 - $125,670
-3,462 Reduced 20.44%
13,478 $479,000
Q1 2019

May 15, 2019
BUY
$31.58 - $46.35 $534,965 - $785,169
16,940 New
16,940 $569,000

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $171M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email